Gain-of-Function Mutations of SLC16A11 Contribute to the Pathogenesis of Type 2 Diabetes
about
Gain-of-Function Mutations of SLC16A11 Contribute to the Pathogenesis of Type 2 Diabetes
description
scientific article published on 01 January 2019
@en
name
Gain-of-Function Mutations of SLC16A11 Contribute to the Pathogenesis of Type 2 Diabetes
@en
type
label
Gain-of-Function Mutations of SLC16A11 Contribute to the Pathogenesis of Type 2 Diabetes
@en
prefLabel
Gain-of-Function Mutations of SLC16A11 Contribute to the Pathogenesis of Type 2 Diabetes
@en
P2093
P50
P1433
P1476
Gain-of-Function Mutations of SLC16A11 Contribute to the Pathogenesis of Type 2 Diabetes
@en
P2093
Lanlan Chen
Qiurong Ding
Tingting Zhou
Yanhao Chen
Yingmin Sun
Yongxian Zhang
Yongxu Zhao
P304
884-892.e4
P356
10.1016/J.CELREP.2018.12.100
P577
2019-01-01T00:00:00Z